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Objective: To provide new data on minimally clinical important difference (MCID) and percentages of
responders on pain and functional dimensions of Western Ontario and McMaster Osteoarthritis Index
(WOMAC) in patients who have undergone total knee replacement (TKR).
Methods: 1-year prospective multicentre study with two different cohorts. Consecutive patients on the
waiting list were recruited. There were 415 and 497 patients included. Pain and function were collected
by the reverse scoring option of the WOMAC (0e100, worst to best). Transition items (ﬁve point scale)
were collected at 1-year and MCID was calculated through mean change in patients somewhat better,
Receiver Operating Characteristic (ROC) and two other questions about satisfaction. Analysis was per-
formed in the whole sample and by tertiles of baseline severity. Likewise were calculated the percentages
of patients who attained cut-off values.
Results: Global MCID for pain were about 30 in both cohorts and 32 for. By ROC these values were about
20 and 24 respectively. According to the other two transitional questions these values were for pain 27
and 20 for function. By tertiles the worst the baseline score the higher the cut-off values. Percentage of
responders does not change when comparing responders to the global MCID with their own tertile MCID
and were about 61% for pain and 50% for function.
Conclusion: Due to the wide variations, MCID estimates should be calculated and used according to the
baseline severity score.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
When considering the expected beneﬁts of total knee replace-
ment (TKR) we are, basically thinking in terms of pain relief,
functional recovery and health-related quality of life. Overall,
literature tells us that TKR is an effective intervention in terms of
patient reported outcomes (PROs)1,2.A. Escobar, Unidad de Investigación
kidetza.net (A. Escobar), lidia.ga
randiaran@osakidetza.net (F.
onzalez Sáenz de Tejada), jo
fermedades Crónicas (REDISSEC), K
s Research Society International. PBut is this intervention really as effective as we think? A recent
study has reported about 44% of patients with persistent pain 3e4
years after the TKR, with even 15% reported as severe-extreme3.
One systematic review4 stated that after TKR there was unfav-
ourable long-term pain outcome in 10e34%. Furthermore, 10e30%
of patients report poor outcomes after intervention in terms of pain
at 1e7 years3,5. Most of the outcomes studied are focused on pain, Hospital Universitario Basurto, Avda. Montevideo 18, 48013 Bilbao, Bizkaia, Spain.
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to improve than function due to the mean age of these patients. In
addition pain is themain complaint for patients electing to undergo
TKR. Functionality related to daily living activities also improves
but this may be closely related to the decrease in pain.
PRO questionnaires are oneway to know howmany patients can
be considered as responders after TKR. They are increasingly used in
clinical practice, but to add some valid information to clinicians they
should be easily interpretable. There are several ways to facilitate
interpretation of these questionnaires. One of the most used is the
Minimally Clinical Important Difference (MCID)6. More recently, the
concept of Patient Acceptable Symptom State (PASS)7,8 deﬁned as
the value beyond which patients consider themselves well and the
Minimal Clinically Important Improvement (MCII)9 deﬁned as the
smallest change in measurement that signiﬁes an important
improvement in a patient’s symptom, have appeared. These con-
cepts are complementary; all are based on external anchoring
questions but while MCID and MCII measure improvement (feeling
better), the PASS measures a satisfactory ﬁnal state (feeling good).
Regarding MCID it is widely recognized that there are no uni-
versal MCID values for a given PRO, but it may vary by patient’s
characteristics or different clinical context. Therefore, the MCID of
an instrument cannot be trusted if determined in only one study or
by one method2.
In TKR, there are few studies10e13 which provide data on the
MCID. Three of them10,11,13 provide data at 6 months or 2 years. In
the remaining12 theMCID cut-off points were studied at 1 year after
surgery. On the other hand it has been argued that MCID based on a
sample global value may result in a signiﬁcant proportion of in-
dividuals being misclassiﬁed as having no beneﬁt and, therefore,
MCIDs should be reported taking into account the baseline score14.
The main goal of this study was to provide new data on MCID
and responders at 1 year in patients who have undergone TKR,
measured by pain and functional dimensions of Western Ontario
and McMaster Universities Osteoarthritis Index (WOMAC) which
could facilitate the interpretation of WOMAC changes.
Methods
We have included two cohorts of patients waiting for TKR. The
ﬁrst study took place in six public hospitals belonging to the Basque
Health Service-Osakidetza, a local government agency in the Bas-
que Country. The second cohort is also a 1-year prospective study
that took place in 15 hospitals; three in Andalusia, three in the
Canary Islands and nine in the Basque Country (Spain). Consecutive
patients placed on the waiting list to undergo primary TKR for
osteoarthritis between September 2003 and September 2004 and
between March 2005 and December 2006 and managed in any of
the hospitals were eligible for the study. In both studies, patients
with psychiatric diseases were excluded because these could pre-
vent them from ﬁlling out the questionnaires of the study. We
collected data from medical records and directly from patients. We
sent to the patients questionnaires at baseline and 12 months post-
surgery. All patients received a letter informing them about the
study and asking for their voluntary participation. The Institutional
Review Boards of the Hospitals approved both studies. The data
used in this study comprise a subset of patients who have
completed preoperative and postoperative health related quality of
life questionnaires and all the transition questions.
We used the WOMAC that is a disease-speciﬁc, self-adminis-
tered questionnaire15. It has a multidimensional scale made up of
24 items grouped into three dimensions: pain (ﬁve items), stiffness
(two items), and physical function (17 items). We have studied pain
and function dimensions through the Likert version with ﬁve
response levels, representing different degrees of intensity: none(0), mild (1), moderate (2), severe (3) or extreme (4). The ﬁnal
scores were determined by adding the corresponding items for
each dimension, and standardizing to a range of values from 0 to
100. According to recent recommendations16 we have used the
reverse option, from 0 (worst) to 100 (best). The WOMAC has been
translated and validated into Spanish17,18.
Statistical analysis
Descriptive statistics included frequencies and percentages for
categorical variables and means and standard deviations (SDs) for
continuous variables. We compared between both cohorts the
sociodemographic data and WOMAC domains at baseline and 1
year after the intervention. Chi-square test was used for comparing
categorical variables, whereas Student’s t test or the nonparametric
Wilcoxon test was used for continuous variables.
We used different statistical methods to calculate the cut-off
values for MCID which has been deﬁned6 as the smallest differ-
ence between the scores in a questionnaire that the patient per-
ceives to be beneﬁcial. All patients had to answer two raw
transition items (RTI), about their improvement or deterioration,
one about pain and another about function 1 year after TKR
(Compared to before surgery, how would you rate pain (functional
limitation) in the same knee?). The ﬁve responses were “a great
deal better”, “somewhat better”, “equal”, “somewhat worse” and “a
great deal worse”. TheMCIDwas estimated for both domains by the
mean change score for those patients who, declared changes
“somewhat better” in the RTI taking the difference between the
score at 1 year and at the baseline19. Second, we have used the
Receiver Operating Characteristics (ROC) curve approach, consid-
ering the dichotomized RTI (a great deal better and somewhat
better vs equal, somewhat worse and a great deal worse) as the
dependent variable, and the change score for each dimension as
independent. As optimal cut-off value of each dimension, the one
which maximized the sum of sensitivity and speciﬁcity was
considered. We draw 500 bootstrap samples20, calculated their
respective ROC curves and derived the 95% conﬁdence interval (CI).
To assess the usefulness of RTI in establishing theMCID, we have
evaluated their validity and reliability12. Validity through the as-
sociation between RTI and the change score in pain and function, by
means of partial correlation coefﬁcients, controlling for baseline
score.We hypothesized that correlation should be higher than 0.521.
We evaluated the correlation among RTI and pre and post-scores by
Spearman’s correlation coefﬁcient. Reliability (internal consistency)
was studied by Cronbach’s alpha of the two RTI, pain and function
items combined. According to recommendations, we have esti-
mated the standard error of measurement (SEM), which represents
the amount of error associated with an individual subject assess-
ment by the formula SEM¼ SD [(1 R)1/2] where SD is the baseline
standard deviation and R is the Cronbach’s alpha reliability coefﬁ-
cient in our samples. At the individual level, SEM should be smaller
than MCID/4 to distinguish MCID from measurement error22.
As recommended23 we have also calculated MCID through two
different independent anchor questions. First: Was the surgery
worthwhile? The answers were: deﬁnitely yes, probably yes,
probably not and deﬁnitely not. TheMCIDwas calculated in patients
who scored “probably yes”. The second question was: What is your
global level of satisfaction with surgical management? The answers
were, very satisﬁed, somewhat satisﬁed, somewhat dissatisﬁed and
very dissatisﬁed.We considered “somewhat satisﬁed” in calculating
MCID. We have chosen these answers because are the closest to
“somewhat better” in the RTI about pain and function dimensions.
For each cut-off value, the percentage of patients exceeding the
MCID (responders) with the 95% CI was estimated. Analyses were
performed globally and according to baseline severity tertiles.
Table I
Sample characteristics by cohort
First cohort
(n ¼ 415)
Second cohort
(n ¼ 497)
P-value
Female, n (%) 296 (71.3) 345 (69.4) 0.6
Mean (SD) Mean (SD)
Age 71.4 (6.7) 71.4 (7.0) 1
BMI* 30.1 (4.4) 30.3 (4.8) 0.5
WOMACy scores
Presurgery pain 44.2 (17.3) 44.6 (18.7) 0.7
Worst tertile 24.4 (10.2) 24.3 (10.4) 1
Medium tertile 45.4 (4.3) 44.9 (4.1) 0.4
Best tertile 63.1 (8.5) 64.3 (9.6) 0.2
Pain at 1 year 78.1 (16.4) 78.7 (19.6) 0.6
Worst tertile 74.4 (20.0) 76.1 (21.3) 0.5
Medium tertile 78.4 (14.2) 77.2 (18.9) 0.5
Best tertile 81.5 (13.8) 82.7 (18.0) 0.5
Presurgery function 38.3 (17.3) 38.8 (17.6) 0.7
Worst tertile 19.6 (7.7)/141 19.4 (8.4)/164 0.8
Medium tertile 38.1 (4.7)/134 39.0 (4.2)/173 0.08
Best tertile 57.6 (8.6)/140 58.5 (9.9)/160 0.4
Function at 1 year 69.3 (18.9) 72.0 (20.8) 0.04
Worst tertile 65.5 (22.2) 65.8 (23.3) 0.9
Medium tertile 69.2 (17.3) 73.4 (18.9) 0.04
Best tertile 73.2 (16.1) 76.6 (18.7) 0.09
Tertiles of pain: ﬁrst cohort (second cohort): worst: 37.5 (35); medium: 38-50
(35.5e50); best: >50 (>50)
Tertiles of function ﬁrst cohort (second cohort): worst 29.4 (31.7): medium:
29.5e45.6 (31.8e45.6): best: >45.6 (>45.6)
Sample size in each tertile ﬁrst cohort (second cohort): worst: 134 (169); medium:
147 (156); best: 134 (172)
* Body mass index
y WOMAC range from 0 to 100; worst to best
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question: “If you had to be the rest of your life with the symptoms
you have now, howwould you feel? Response categories were very
satisﬁed, somewhat satisﬁed, somewhat dissatisﬁed and very
dissatisﬁed. For analysis we grouped the ﬁrst two into satisﬁed
patients8.
We considered statistically signiﬁcant P < 0.05. All statistical
analyses were performed using SAS for Windows version 9.2 (SAS
Institute, Inc., Cary, NC), and Conﬁdence Interval Analysis v.2.2.
Results
Samples description
There were 415 and 497 patients in the ﬁrst and second cohorts
respectively. In both groups, about 70% were females, the mean age
was 71 years old and the mean Body Mass Index (BMI) was 30. As
can be seen in Table I both in total sample and sample data divided
by baseline severity tertiles, there were no statistical differences
between cohorts, except in the scores at 1 year in the functional
dimension. As it was expected, there were large improvements,
both in pain and function, about 34 and 32 points, respectively. In
both groups from the worst to best tertile, gains in pain were about
51, 33 and 18 points respectively, and about 46, 33 and 17 points in
the function dimension. This is, the worse the baseline status the
higher the gains.
In comparing baseline pain, function, age, BMI and gender, there
were no differences between patients included and not included in
the ﬁrst cohort. In the second, non-included patients scored ﬁve
points higher in pain and function and, there were 6%more females
(data not shown).
RTI
The partial correlation coefﬁcients between RTI-change scores
in pain were 0.53 (ﬁrst cohort) and 0.62 (second cohort), while for
function they were 0.42 and 0.60, respectively. The correlation
between RTI-baseline pain was 0.03 and 0.05 in the ﬁrst and
second cohort, while with the 1-year score it was 0.62 and 0.47. As
regards function, these values were 0.03 and 0.08 for baseline
scores and 0.60 and 0.48 for 1 year, respectively. Reliability values
for the combined RTI were 0.70 and 0.80 in the ﬁrst and second
cohort, respectively.
MCID for pain
Table II shows data on the SEM and MCID in the pain dimension
with their 95% CI along with the percentage of patients who were
above those values. The SEMs were 8.6 and 8.3 in the ﬁrst and
second cohort. Regarding global MCID is about 29 points in both
cohorts. The values according to the baseline tertiles of severity
were similar in both cohorts, around 45, 28 and 15 points in the
worst, medium and best tertiles, respectively. The global value
obtained by ROC analysis was about 22 points. There was a major
difference in the worst tertile, being 30 points in the ﬁrst cohort
and 40 in the second one, while the other two tertiles were quite
similar, around 23 in medium and 10 points in the best tertile. The
MCID according to the two additional transitional questions, were
around 27 points, similar and close to the global MCID.
MCID for function
In Table III there is the same data as previously shown but on the
function dimension. The SEM values were 5.1 in the ﬁrst cohort and
4.6 in the second. Global MCID was about 32 points. According tothe baseline tertiles of severity, both groups showed similar values,
which from worst to best were around 45, 33 and 17. The cut-off
values established by ROC were also similar in both groups. The
global value was around 24 points, and from worst to best tertile
were 40, 27 and 15 points. Data about the cut-off points in the two
other transitional questions had a mean value of 22 points (range:
18.8e25.8).
Responders
Table IV shows data on percentage of responders and their 95%
CI according to the values of the global MCID, by tertile of baseline
scores and satisﬁed patients. According to the global MCID, the
percentage of responders in pain was similar between cohorts,
61.9% and 63.4%. These percentages increased as the baseline
severity increased (more responders in the worst tertile) with
similar percentages in both cohorts in all tertiles, varying from
31.6% to 87%. According to theMCID by tertiles, the total percentage
of patients considered as responders was 60.9% and 69.6% in each
cohort respectively. According to the tertiles these percentages
ranged from 55.9% to 66.9% in the ﬁrst and from 66.0% to 71.6% in
the second cohort. When considering the function dimension, the
percentages of responders to the global MCIDwere 48.7% and 49.8%
in the ﬁrst and second cohort. As before, these percentages were
higher in the worst tertile ranging from 20.6% to 74.1% in the ﬁrst
cohort and from 18.5% to 72.4% in the second one. If we look at the
responders according to their own MCID by tertile, patients clas-
siﬁed as responders were 50.4% and 53.0%. These percentages
ranged from 46.3% to 55.2% and from 51.6% to 55.2% in the ﬁrst and
second group respectively.
Satisfaction
Satisfaction with their “current” symptomatology was attained
by 78.5% and 78.9% of patients in each cohort. By tertiles of pain
Table II
MCID data for the WOMAC pain domain
First cohort (n ¼ 415) Second cohort (n ¼ 497)
Cut-off value (95% CI) Patients %x Cut-off value (95% CI) Patients %x
SEM* 8.6 8.3
MCIDy globalz 29.9 (27.1e32.6) n ¼ 209k 61.9 28.1 (25.1e31.0) n ¼ 207k 63.4
MCIDy tertilesz
Worst 46.4 (40.6e52.2) n ¼ 59k 60.9 44.5 (39.9e49.2) n ¼ 67k 69.6
Medium 29.9 (26.7e33.1) n ¼ 75k 27.1 (23.4e30.7) n ¼ 71k
Best 16.8 (13.6e20.0) n ¼ 75k 13.1 (8.8e17.4) n ¼ 69k
ROC global 20.5 (20.2e20.9) 70.2 23.5 (23.1e23.8) 72.4
Worst 29.8 (29.2e30.5) 84.6 40.7 (40.2e41.1) 71.6
Medium 21.1 (20.7e21.5) 78.4 25.0 (24.7e25.3) 66.0
Best 11.7 (11.2e12.2) 71.3 9.0 (7.8e10.2) 75.0
Was the surgery worthwhile?
- Patient’s answer: Probably YES, n (%) 96 (23.1) 103 (20.7)
MCIDy 28.0 (23.6e32.4) 61.3 25.6 (21.6e29.7) 64.0
What is your global level of satisfaction with surgical management?
- Patient’s answer: Somewhat satisﬁed, n (%) 115 (27.7) 138 (27.8)
MCIDy 25.2 (21.9e28.5) 61.3 27.5 (23.7e31.4) 63.4
Tertiles of pain: ﬁrst cohort (second cohort): worst: 37.5 (35); medium: 38e50 (35.5e50); best: >50 (>50).
ROC: calculated as the point that maximized the sum of sensitivity and speciﬁcity.
* SEM: standard error of measurement.
y MCID: Minimal clinically important difference.
z Calculated as mean change in those patients who were “somewhat better”.
x Percentage of patients exceeding the cut-off value.
k Sample size in the “somewhat better category”.
A. Escobar et al. / Osteoarthritis and Cartilage 21 (2013) 2006e2012 2009severity, percentages varied from 77.8% to 79.2% in the ﬁrst cohort,
and from 75.1% to 84.9% in the second. By tertiles of function, they
ranged from 75.6% to 81.6% and from 74.8% to 82.0% in each cohort
respectively.
Discussion
In this study of two cohorts we have used several ways to
establish cut-off values for patients to be considered as responders
according to MCID. The fact of using two cohorts could be seen as a
way of validating the values obtained. This study provides more
information on the improvement scores which can be used as a
reference when considering WOMAC after TKR.Table III
MCID data for the WOMAC function domain
First cohort (n ¼ 415)
Cut-off value (95% CI)
SEM* 5.1
MCIDy globalz 31.1 (28.3e33.9) n ¼ 221{
MCIDy tertilesz
Worst 44.1 (39.4e48.9) n ¼ 76{
Medium 32.8 (29.1e36.5) n ¼ 70{
Best 16.3 (12.8e19.9) n ¼ 75{
ROCx global 24.2 (23.6e24.7)
Worst 43.3 (42.6e44.0)
Medium 26.8 (26.3e27.3)
Best 15.3 (14.9e15.8)
Was the surgery worthwhile?
- Patient’s answer: Probably YES, n (%) 96 (23.1)
MCIDy 20.6 (16.4e24.8)
What is your global level of satisfaction with surgical management?
- Patient’s answer: Somewhat satisﬁed, n (%) 115 (27.7)
MCIDy 18.8 (15.7e21.9)
Tertiles of function ﬁrst cohort (second cohort): worst 29.4 (31.7): medium: 29.5e45
* SEM: standard error of measurement.
y MCID: Minimal clinically important difference.
z Calculated as mean change in those patients who were “somewhat better”.
x Receiver Operating Characteristic: calculated as the point that maximized the sum o
k Percentage of patients exceeding the cut-off value.
{ Sample size in the “somewhat better category”.Wemay consider our RTI correlation values as the usual reported
in the literature regarding their reliability and validity. All RTI-
change score partial correlations were above 0.5 except that of
function in theﬁrst cohort,whichwas in thevicinity of this threshold
value. As it was expected, we have obtained a high positive corre-
lationwith the 1-year score and a near zero correlationwith baseline
scores in both dimensions which implies that patients do not
remember properly their baseline state24. Reliability measured by
Cronbach’s alpha showedvalues considered as acceptable or good. In
both cases our data were slightly lower than others published12.
There are some published MCID values for WOMAC based on
absolute change10e12. Values are different and this could be inter-
preted in at least three ways. First, the timeframe in which valuesSecond cohort (n ¼ 497)
Patients %k Cut-off value (95% CI) Patients %k
4.6
48.7 33.5 (30.9e36.0) n ¼ 237{ 49.8
50.4 45.6 (40.9e50.3) n ¼ 81{ 53.0
33.9 (30.6e37.1) n ¼ 82{
19.7 (16.7e22.7) n ¼ 74{
61.2 23.0 (22.7e23.2) 69.7
58.0 39.7 (39.1e40.4) 61.3
60.3 27.1 (26.7e27.5) 69.8
52.5 14.7 (14.3e15.0) 65.6
103 (20.7)
84.6 22.5 (19.0e26.1) 68.9
138 (27.8)
86.5 25.8 (22.4e29.2) 63.0
.6 (31.8e45.6): best: >45.6 (>45.6).
f sensitivity and speciﬁcity.
Table IV
WOMAC pain and function dimensions: percentage of patients attaining global
MCID, their own MCID by tertile and satisﬁed patients
Baseline tertile, % Total, % (95% CI)
Worst Medium Best
Pain dimension
First* cohort (n ¼ 415)
MCID* global 84.6 66.9 31.6 61.9 (57.1e66.7)
MCID by tertile 57.4 66.9 55.9 60.9 (56.1e65.8)
Satisﬁedy 77.8 78.4 79.2 78.5 (74.4e82.6)
Second* cohort (n ¼ 497)
MCID global 87.0 65.4 38.4 63.4 (59.1e67.7)
MCID by tertile 71.6 66.0 70.9 69.6 (65.5e73.8)
Satisﬁedy 75.1 76.3 84.9 78.9 (75.2e82.6)
Function dimension
First* cohort (n ¼ 415)
MCID global 74.1 49.3 20.6 48.7 (43.7e53.6)
MCID by tertile 55.2 46.3 47.5 50.4 (45.4e55.3)
Satisﬁedy 78.9 75.6 81.6 78.5 (74.4e82.6)
Second* cohort (n ¼ 492)
MCID global 72.4 57.0 18.5 49.8 (45.3e54.3)
MCID by tertile 55.2 52.3 51.6 53.0 (48.5e57.6)
Satisﬁedy 74.8 82.0 79.9 78.9 (75.2e82.6)
* MCID: Minimal Clinically Important Difference.
y Question was: “If you had to be the rest of your life with the symptoms you have
now, how would you feel?” Responses categories: very satisﬁed, somewhat satis-
ﬁed, somewhat dissatisﬁed and very dissatisﬁed.
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patients with TKR at 6 months or at 2 years10. Second, these are
values that strongly rely on the kind of population included in the
study; threshold of improvement should be different in patients
with TKR than in thosewithmedical treatment or patients included
in a rehabilitation programme. The fact that those TKR patients
who are located in the best pain tertile have much lower MCID
values than their sample global MCID and close to those with
medical treatment, about 15.525 could serve as a reference. Third,
values rely on how they are calculated, as a mean change in one
category in the RTI, as our work or as the difference in mean change
between adjacent categories. These facts should be taken into ac-
count when comparing MCID cut-off points. Our work presents
data at 1 year for TKR and calculated through RTI taking patients
classiﬁed as “somewhat better” to establish changes.
Our data show an important improvement in the pain and
functional dimensions at 1 year post-surgical management. As in
others studies1,26 the worse the baseline score the higher the
improvement in both dimensions. A recent review4 reported that
the proportion of patients with long-term pain outcome after TKR
was high and in those studies with the best quality this proportion
was about 20%. In this paper, when using WOMAC pain dimension
to measure unfavourable pain outcome these percentages varied
according to the chosen criteria. For instance, using as a cut-off
value 10/100, there was an 18.5% of patients who did not
improve; our data (not shown) are slightly lower with 14.3% and
12.9% in each group. When using MCID of 22.6 points calculated
with one transition question for both dimensions13 this percentage
was 33.1% while in our series with two transitions questions these
cut-off values given percentages of 29.8% and 27.6% (data not
shown) in the ﬁrst and second cohort respectively. According to our
results, there are about 38.1% (ﬁrst cohort) or 36.6% (second) of
patients who have not reached the global MCID for pain.
It is well known9,14 that MCID can change according to baseline
severity. Therefore, it is considered appropriate to establish cut-off
points according to them in order to calculate the percentage of
patients who can be considered as responders within their own
baseline tertile, rather than to a sample MCID. Our data show
different cut-off points in each tertile, the worse the baseline statusthe higher the needed score, and different percentages of re-
sponders according to their own tertile. Cut-off points were very
different in each tertile but percentages of responders were similar
according to the global MCID or to the MCID by tertile. Therefore,
although MCID should be calculated by tertiles, this fact does not
change the overall percentage of patients considered as responders.
Therefore, with our data there is no important effect of the baseline
score. For instance, in our second cohort, patients who are
considered as responders to their own tertile MCID and not to
global MCID (n ¼ 57) were all located in the best baseline situation,
and vice versa, there were 26 patients who were responders to
global MCID and not to their own tertile, all of them were in the
worst baseline situation. So the misclassiﬁcation of patients based
on global MCID plays a role in both directions.
Although we agree with Davis et al.14 in the existence of a third
group of patients whowould be classiﬁed as non-responders due to
the ceiling (or ﬂoor) effect of a questionnaire and that there are
another variables apart from pain and functional ability, which
could inﬂuence the decision to perform TKR27,28, our percentages of
patients who could not reach the global sample MCID was much
lower than those reported by them. In the pain dimensionwe had a
4.3% and 6.8% in the ﬁrst and second cohort of patients who could
not reach MCID. In the previous report there was 28.8%. Clearly, all
these patients are in the lower pre-surgery pain tertile, which is the
best situation. When groups have this or similar percentages of
patients located in the best baseline situation, analysis by tertiles
can have higher importance given that those are the patients who
cannot attain global MCID but more easily reach the MCID of their
baseline tertile. Although there are conﬂicting results in the litera-
ture29,30, these differencesmay be due to the time the baseline score
was collected, possibly the timeon thewaiting list could inﬂuence it,
or it can be affected when others factors apart from pain or func-
tional disability have a major inﬂuence on decisions to surgery.
As in other study12, we have considered helpful to use another
external criterion of change, such as those presented in Tables II and
III. In the case of pain, the thresholds of these questions are slightly
lower than MCID with their own RTI, as in the cited study. With
these data, we could state that the global MCID for pain in patients
with TKR at 1 year would be around 30 points. This ﬁgure repre-
sents a 30% improvement over the baseline scorewhich agreeswith
other consensus statements on pain31 and a validation study of this
statement using an objective functional external anchor32 in pain or
function carried out in patients with lumbar disorders. It was stated
that a change of at least 30% was considered as moderately
improvement. We may also say that this value is similar to that
reported by Chesworth et al.12.
As before, cut-off values calculated through the ROC analysis
varies depending on the baseline score being the worst patients
who need the greater improvement to attain them. ROC analysis
consistently presents more conservative values for MCID. However,
these values are based on a small number of non-improved patients
indicating poor reliability.
Considering satisfaction with symptomatology, the percentage
of patients who considered themselves satisﬁed is more stable
along tertiles of baseline severity and always higher than re-
sponders to the MCID by tertile. This question has been previously
considered as a PASS estimate8 and shows that the percentage of
responders can be considered independently of baseline scores.
Our percentage of satisﬁed patients, around 80%, is similar to others
published33e35.
Regarding physical functioning, our global MCID was about 32
points and it is close to another reported value of 33 points12 and
our 23e24 points calculated by ROC is also similar to 22.8 points
reported by Terwee et al.11. In addition, results of both of our cohorts
are very similar. In this case our estimated values are higher than
A. Escobar et al. / Osteoarthritis and Cartilage 21 (2013) 2006e2012 2011those calculated with one transition question10 at 6 months (19.1)
or at 2 years (20.8). As in the pain dimension, cut-off points by
tertiles were higher in the worst baseline status in all three
methods. However, in this dimension, MCID calculated by the two
other anchor questions, were lower and closest to the ROC values
than to the global MCID. All comments on responders vs non-
responders and analysis by tertiles performed on pain are appli-
cable to the function dimension.
If we consider the percentage of global MCID responder and
those of responders according to their own tertile, we can see that
both are similar with a slight increase if we consider data divided by
tertiles.
There are some possible limitations in the study. It is well
known that the use of retrospective RTI is subject to recall bias, so
the validity of these retrospective items could be threatened. Pa-
tients non-included in the study could bias the results, but our data
do not seem to appreciate differences between participants and
excluded patients. ROC values are based on a small number of non-
improved patients, so the result can be unreliable. Finally, our pain
SEM values were high and therefore don’t seem to be adequate to
use in individual patients, although our values of MCID/4 are close
to the SEM.
In conclusion, data of both groups are similar; the global MCID
can be considered around 30 points and 32 for pain and functional
dimensions. Data calculated by ROC analysis are always lower and
around 22 points for pain and 23 for function dimension. Theworse
the baseline status the higher the cut-off point obtained by any
method. Although cut-off points should be calculated by baseline
tertiles of severity, the percentage of responders is similar if we
calculate it by means of the global sample MCID as if we do it by
means of the MCID by tertiles.Author contributions
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